Dr. Gunjan Bhardwaj is the founder and CEO of the Innoplexus AG, a leading global AI champion in the field of drug discovery & development. Gunjan was earlier with the Boston Consulting Group and before that the leader of the global business performance think-tank of Ernst & Young. He has authored publications in journals such as Harvard Business Review and MIT Sloan Review, wrote several books, and appeared as a keynote speaker at various international life science events.